Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pregabalin Abuse Liability in Benzodiazepine Withdrawal
NCT02423018Phase 4Terminated
- Sponsor
- Center for Addiction and Mental Health
- Start
- Apr 2015
- Primary completion
- Mar 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of pregabalin in benzodiazepine withdrawal syndrome (BWS), sponsored by Center for Addiction and Mental Health. Started Apr 2015; status: terminated.
02
Drugs
pregabalin
03
Conditions
benzodiazepine withdrawal syndrome (BWS)
Beyond the preview
Go deeper on NCT02423018.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02423018.